Filing Details
- Accession Number:
- 0000899243-22-018935
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-19 19:06:51
- Reporting Period:
- 2022-05-17
- Accepted Time:
- 2022-05-19 19:06:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1590947 | F. Robert Werner | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-05-17 | 7,356 | $3.81 | 204,655 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-19 | 2,746 | $3.40 | 201,909 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Includes 405 and 1,811 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on November 12, 2021 and May 13, 2022, respectively.
- Includes an aggregate of 187,924 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The sales of common stock were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 10, 2020.